Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
APVO
NXL
Add up to 3 more stocks
APVO
Aptevo Therapeutics Inc.
+0.79%
$1.81+0.01Delayed quote: Oct 6, 2026, 1:22 PM EDT
Market Cap
$3.97M
52W Range
$1.37 - $35.64
NXL
Nexalin Technology, Inc.
-10.13%
$4.88-0.55Delayed quote: Oct 6, 2026, 1:38 PM EDT
Market Cap
$3.58M
52W Range
$4.00 - $60.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.66 | 2.36 |
| P/S Ratio | N/A | 16.49 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 79.7% |
| Operating Margin | 0.0% | -2781.7% |
| Net Margin | 0.0% | -4139.4% |
| ROE | -437.1% | -591.6% |
| ROA | -181.9% | -299.2% |
| ROIC | -288.1% | -600.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.08 | 1.25 |
| Quick Ratio | 2.08 | 1.10 |
| Debt/Equity | 0.70 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.